Despegar is a highly profitable company, with Over the past two decades, Despegar has developed and grown into a sector leader with a proven and scalable business model. The company handles over 9.5 ...
Fueled by innovation and rising chronic diseases, organoids and spheroids in Asia Pacific revolutionize personalized medicine, regenerative therapies ...
The term “greenwashing” is not associated with money laundering or corporate espionage, but to misleading (and highly unethical) claims by asset managers that their fund(s) are environmental, social ...
New Delhi, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The US meniscus treatment market is projected to hit the market valuation of US$ 479.38 million by 2033 from US$ 237.87 million in 2024 at a CAGR of 8.24% ...